Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). [electronic resource]
- Blood Oct 2002
- 2717-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0006-4971
10.1182/blood-2002-03-0990 doi
Adolescent Adult Bone Marrow--pathology CCAAT-Enhancer-Binding Protein-alpha--genetics Female Follow-Up Studies France Humans Leukemia, Myeloid, Acute--blood Male Middle Aged Mutation Prognosis Sequence Deletion Survival Rate Time Factors Treatment Outcome United Kingdom United States